Four or 24 hours after ischemia onset via eMCAO, 20 mg of FITC-albumin (Sigma, Taufkirchen, Germany; in 1 mL physiological saline solution [NaCl]) was administered intravenously. The gene discussed is ALB; the disease is ischemia.